LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...

I appreciate devices that don’t try to do too much. There are too many products throwing too many features at the consumer in ...

I can't imagine traveling without my XR glasses anymore. If you're thinking about trying them on your next trip or commute, ...